We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Bbi Hldgs | BBI | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 185.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 185.00 | 185.00 |
| Top Posts |
|---|
Posted at 11/6/2007 13:19 by shuisky Agreed. It's unfair that small retail investors should be exposed to this kind of thing. I was amazed that the share price got to 180p, primarily because the ex-Theratase shareholder selling was a given. It maybe creating a decent entry point for the rest of us, but I'd hoped for a lower price than this! |
Posted at 18/1/2007 16:52 by shuisky Yes I agree, and I bought some more on some recent weakness.One thing that intrigues me is that the press (including the Guardian tip) don't seem to have picked up on the fact that their partner Verax Biomedical has signed a major exclusive worldwide marketing and distribution agreement with Abbott Labs... ...and Abbott Labs are a major worldwide player. Of course, BBI has 10 year manufacturing agreement to manufacture the Verax Platelet PGD Test. AFAICS, Their broker has left forecasts unchanged on 10.4x 2008 Earnings. Granted, it's no certainty that the Platelet will be a success and it will take time to build up sales, but Abbott Labs is a 77bn Gorilla in the industry and already has fantastic distribution channels.IMHO, the poosibility of GE buying Abbott Labs Diagnostic business should not have an effect on this. The sells today look like a host of small retail punters selling out or reducing position. Everyone's intitled to take some profit. FWIW, I don't think now is the time to sell out, but retail investors will do strange things. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
